text.skipToContent text.skipToNavigation

Maximum quantity allowed is 999

Gelieve het aantal te selecteren

Glycogen Synthase Kinase 3 (GSK3) Inhibitor: SB 216763

No.179(November 2018)
B5716
SB 216763 (1)

1

SB 216763 (1) is a potent and selective cell permeable glycogen synthase kinase 3 (GSK3) inhibitor.1) The inhibitory mechanism is ATP-competitive. The Ki and IC50 of 1 to GSK-3α are 9.10 nM and 34.3 nM, respectively.
1 can maintain mESCs in a pluripotent state in the absence of exogenous leukemia inhibitory factor (LIF) when cultured on mouse embryonic fibrobrasts (MEFs).2) 1 promotes the generation of hematopoietic stem cells (HSCs) in aorta-gonad-mesonephros (AGM) explants.3)
This product is for research purpose only.

References

The prices are subject to change without notice. Please confirm the newest price by our online catalog before placing an order.
In addition, sales products changes with areas. Please understand that a product is not available when the product details page is not displayed.
Sessiestatus
Uw sessie verloopt over 10 minuten. Na het verlopen van de sessie word u doorgestuurd naar de startpagina. Klik op de knop om de sessie vanaf dezelfde pagina voort te zetten. minuut. Na het verlopen van de sessie word u doorgestuurd naar de startpagina. Klik op de knop om de sessie vanaf dezelfde pagina voort te zetten.

Uw sessie is verlopen. U wordt doorgestuurd naar de startpagina.